Bioresponsive Protein Complex of aPD1 and aCD47 Antibodies for Enhanced Immunotherapy

doi 10.1021/acs.nanolett.9b00584.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

In Vitro Evolution of Enhanced RNA Replicons for Immunotherapy

Scientific Reports
Multidisciplinary
2019English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

Frontiers in Immunology
AllergyImmunology
2017English

Seasonal Changes in IgE Antibodies and Their Relationship to IgG Antibodies During Immunotherapy for Ragweed Hay Fever

Journal of Clinical Investigation
Medicine
1973English

Enhanced Immunotherapy by Combining a Vaccine With a Novel Murine GITR Ligand Fusion Protein

Oncotarget
Oncology
2017English

Bioresponsive Matrices in Drug Delivery

Journal of Biological Engineering
Biomedical EngineeringEnvironmental EngineeringCell BiologyMolecular Biology
2010English

Comprehensive Engineering of Escherichia Coli for Enhanced Expression of IgG Antibodies

Metabolic Engineering
Applied MicrobiologyBiotechnologyBioengineering
2011English

New Tricks for Old Targets: Anti-Ctla-4 Antibodies Re-Envisioned for Cancer Immunotherapy

Oncotarget
Oncology
2018English

Prospects for Engineering HIV-specific Antibodies for Enhanced Effector Function and Half-Life

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy